Variantyx
PrivateLast Round
VC Round
Apr 26, 2024
Total Funding Raised
$94.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Variantyx operates in Healthcare & Life Sciences and is based in Framingham, Massachusetts. Its latest recorded funding round was a VC Round in April 2024.
Variantyx is a biotechnology company that provides whole genome sequencing and analysis services for diagnosing rare inherited disorders, reproductive health, and precision oncology.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Variantyx Comparables
Compare Variantyx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GeneDx Holdings Corp. | 83% | |
| 3billion, Inc. | 78% | |
| SIRION Biotech | 77% |
For institutional investors. Book with your work email.
Variantyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 26, 2024 | ||||
| Series C | Oct 18, 2023 | ||||
| Debt | Oct 18, 2022 | ||||
| Series C Extension | Feb 14, 2022 | ||||
| Series C | Mar 15, 2021 | ||||
Series B | Jun 6, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Variantyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | Debt |
| Bosch Ventures | VC Round, Series C, Series C Extension |
| New Era Capital Partners | VC Round, Series C, Series B, Series C Extension |
| Peregrine Ventures (California) | VC Round |
| Kreos Capital | Debt |
| IBM Ventures | Series C |
| GF Financial Markets (UK) Limited | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 51% MoM, reaching 11.3K.
- Oct 14, 2025
Launched proprietary Genomic Unity® testing platform for whole genome sequencing diagnostics.
For institutional investors. Book with your work email.
Variantyx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Variantyx's valuation, stock price, and market status.
Is Variantyx a public or private company?
Variantyx is a private company.
What is the current stock price of Variantyx?
Variantyx is a private company, so its shares have no public market price. Caplight tracks Variantyx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Variantyx worth (valuation)?
Valuation information for Variantyx is not publicly available.
Can I buy Variantyx stock?
Variantyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Variantyx's last funding round?
Variantyx's most recent funding round was VC Round on April 26, 2024.
Who are the main investors in Variantyx?
Key investors in Variantyx include Kreos Capital, New Era Capital Partners, GF Financial Markets (UK) Limited, ERA Capital, Pitango Venture Capital.
Will Variantyx IPO soon?
No public IPO plans have been announced for Variantyx.
How can I track Variantyx secondary market activity?
Caplight tracks bids, offers, and trades in Variantyx's shares on secondary markets.